Regado Biosciences, Inc. (RGDO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Regado Biosciences, Inc. (RGDO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135815FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Regado Biosciences, Inc. (Regado) is a pharmaceutical company. The company discovers and develops actively controllable antithrombotic drug systems for acute and sub acute cardiovascular indications. Its products include REG1, REG2 and REG3. The company’s lead product candidate, REG1, is an actively controllable anticoagulant targeting coagulation factor IXa for use in patients with a wide variety of acute coronary syndromes, or ACS, undergoing a percutaneous coronary intervention. Its products under development also comprise REG2, which is in Phase I clinical trials for the venous thrombosis indications treatment, and REG3, a preclinical stage antiplatelet therapy for diabetic vasculopathy and other inflammatory diseases. Regado is headquartered in Basking Ridge, New Jersey, the US.

Regado Biosciences, Inc. Key Recent Developments

Dec 17, 2013: Regado Biosciences Adds World-Class Interventional Cardiologist and Researcher to Medical Advisory Board
Dec 09, 2013: Regado Biosciences Strengthens Executive Leadership
Dec 06, 2013: Regado Biosciences to Present at Oppenheimer’s 24th Annual Healthcare Conference
Nov 18, 2013: Regado Biosciences Adds Global Pharmaceutical Business Veteran to Board of Directors
Nov 07, 2013: Regado Biosciences Announces Third Quarter 2013 Results

This comprehensive SWOT profile of Regado Biosciences, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regado Biosciences, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Regado Biosciences, Inc. – Key Information
Regado Biosciences, Inc. – Overview
Regado Biosciences, Inc. – Key Employees
Regado Biosciences, Inc. – Key Employee Biographies
Regado Biosciences, Inc. – Key Operational Heads
Regado Biosciences, Inc. – Major Products and Services
Regado Biosciences, Inc. – History
Regado Biosciences, Inc. – Company Statement
Regado Biosciences, Inc. – Locations And Subsidiaries
Regado Biosciences, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Regado Biosciences, Inc. – Business Description
Regado Biosciences, Inc. – Corporate Strategy
Regado Biosciences, Inc. – SWOT Analysis
SWOT Analysis – Overview
Regado Biosciences, Inc. – Strengths
Regado Biosciences, Inc. – Weaknesses
Regado Biosciences, Inc. – Opportunities
Regado Biosciences, Inc. – Threats
Regado Biosciences, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Regado Biosciences, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Regado Biosciences, Inc., Key Information
Regado Biosciences, Inc., Key Ratios
Regado Biosciences, Inc., Share Data
Regado Biosciences, Inc., Major Products and Services
Regado Biosciences, Inc., History
Regado Biosciences, Inc., Key Employees
Regado Biosciences, Inc., Key Employee Biographies
Regado Biosciences, Inc., Key Operational Heads
Regado Biosciences, Inc., Other Locations
Regado Biosciences, Inc., Subsidiaries
Regado Biosciences, Inc., Key Manufacturing facilities
Regado Biosciences, Inc., Key Competitors
Regado Biosciences, Inc., SWOT Analysis
Regado Biosciences, Inc., Ratios based on current share price
Regado Biosciences, Inc., Annual Ratios
Regado Biosciences, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Regado Biosciences, Inc., Performance Chart
Regado Biosciences, Inc., Ratio Charts

★海外企業調査レポート[Regado Biosciences, Inc. (RGDO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eleme Medical, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eleme Medical, Inc. Mergers and …
  • Endeavour Silver Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Endeavour Silver Corp. Mergers …
  • Total E&P Canada Ltd.:企業のM&A・提携動向(石油・ガス分野)
    Summary Total E&P Canada Ltd. (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that provides oil and gas exploration and production services. The company offers crude oil, liquefied natural gas, petrochemicals, fertilizers, and specialty chemicals. Its oil sands projects port …
  • Catalis SE (XAE1):企業概要、財務及び戦略的SWOT分析
    Summary Catalis SE (Catalis) is a provider of technical service. The company provides technical services related to the creation of digital content for the digital media and entertainment industries. Its products include Power Star Golf and Zumba World Party. Catalis also designs and develops electr …
  • Media Prima Berhad (MEDIA):企業の財務及び戦略的SWOT分析
    Summary Media Prima Berhad (Media Prima) is a media company that offers television, NSTP, radio, big tree outdoor, digital and integrated marketing services. The company’s television shows include Anugerah Juara Lagu, The Golden Awards, Jejak Rasul, Majalah 3, Dunia Tersembunyi, Nona, Showdown, Hip- …
  • Capcom Co. Ltd. (9697):企業の財務・戦略的SWOT分析
    Capcom Co. Ltd. (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ceres Power Holdings plc (CWR):企業の財務及び戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost, next generation fuel cell technology. The company offers steel cell, a fuel cell technology that converts natural gas or hydrogen fuel directly into electrical power and heat due in a chemical rea …
  • Taro Pharmaceuticals U.S.A., Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Taro Pharmaceuticals U.S.A., In …
  • RigNet, Inc.の企業概要及び財務/SWOT分析
    RigNet, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, RigNet, Inc. annual and quarterly forecasts made by stock market experts. The report also enables direct comparis …
  • Ziarco Pharma Ltd(製薬・医療分野):企業M&A動向
    Summary Ziarco Pharma Ltd (Ziarco Pharma) is a biotechnology company. The company offers treatment for multiple inflammatory and allergic disorders such as asthma, COPD, allergic rhinitis, lung fibrosis. It also offers treatment for skin related issues such as atopic dermatitis, psoriasis, acute and …
  • The TPL Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The TPL Group Mergers and Acqui …
  • Iris BioTechnologies Inc. (IRSB):企業概要、財務及び戦略的SWOT分析
    Summary Iris BioTechnologies Inc. (Iris BioTechnologies) is a biotechnology company. It focuses on the development and commercialization of Nano-Biochips and an artificial intelligence system, which assists in establishing the foundation for personalized medicine, in the treatment of breast cancer. …
  • Galectin Therapeutics, Inc. (formerly Pro-Pharmaceuticals, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Galectin Therapeutics, Inc. (fo …
  • AmSurg Corp. (AMSG):企業の財務及び戦略的SWOT分析
    Summary Amsurg Corp. (AmSurg) is a healthcare service provider that develops acquires and operates outpatient surgery centers. The company provides services in area of gastroenterology, ophthalmology, knee and shoulder arthroscopy, and orthopedic. Amsurg’s surgery centers offer patient registration, …
  • University of Barcelona(製薬・医療分野):企業M&A動向
    Summary University of Barcelona (UB) is an educational service provider. The university provides educational courses and research programs. It offers bachelor’s degrees, master’s degrees and research doctoral studies. The university offers EHEA bachelor's degree courses, pre-EHEA degree and universi …
  • Huaneng Power International Inc:発電所・企業SWOT分析
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Imperial Tobacco Group PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Imperial Tobacco Group PLC Merg …
  • Digirad Corporation (DRAD):企業財務及び戦略的SWOT分析
    Summary Digirad Corporation (Digirad) is a medical device company that offers on-site imaging solutions. The company offers camera products which include ergo, cardius x-act, cardius 2 XPO and cardius 3 XPO. It provides diagnostic services such as nuclear cardiology, ultrasound, neuropathy testing, …
  • IMI plc (IMI):企業のM&A・提携動向(エネルギー分野)
    Summary IMI plc (IMI) is a specialist engineering company that carries out designing, manufacturing and servicing of highly engineered products that control the precise movement of fluids. It also designs and develops heating and cooling systems. The company offers its products to various industries …
  • Obrascon Huarte Lain, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Obrascon Huarte Lain, S.A. Merg …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆